CMMB Vision Holdings Ltd
HKEX:471
CMMB Vision Holdings Ltd
HKEX:471
Price:
0.61
HKD
-3.17%
Market Closed
Market Cap:
HK$292.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CMMB Vision Holdings Ltd
HKEX:471
|
HK |
|
Nippon Telegraph and Telephone Corp
TSE:9432
|
JP |
|
Eurobio Scientific SA
PAR:ALERS
|
FR |
|
A
|
Alior Bank SA
WSE:ALR
|
PL |
|
PainChek Ltd
ASX:PCK
|
AU |
|
I
|
Insig Ai PLC
LSE:INSG
|
UK |
|
Y
|
Yesil Yatirim Holding AS
IST:YESIL.E
|
TR |
|
K
|
Kyoei Sangyo Co Ltd
TSE:6973
|
JP |
|
Eurobank Ergasias Services and Holdings SA
ATHEX:EUROB
|
GR |
Balance Sheet
Balance Sheet Decomposition
CMMB Vision Holdings Ltd
CMMB Vision Holdings Ltd
Balance Sheet Decomposition is not available for
CMMB Vision Holdings Ltd
CMMB Vision Holdings Ltd
Balance Sheet
CMMB Vision Holdings Ltd
CMMB Vision Holdings Ltd
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
10
|
6
|
1
|
2
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Cash |
10
|
6
|
1
|
2
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Total Receivables |
4
|
6
|
11
|
11
|
9
|
4
|
6
|
8
|
9
|
6
|
|
| Accounts Receivables |
1
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
4
|
1
|
|
| Other Receivables |
2
|
5
|
9
|
9
|
8
|
3
|
5
|
6
|
6
|
5
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
7
|
7
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
14
|
19
|
19
|
13
|
9
|
6
|
7
|
10
|
10
|
7
|
|
| PP&E Net |
27
|
92
|
95
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| PP&E Gross |
27
|
92
|
95
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Intangible Assets |
107
|
107
|
107
|
97
|
81
|
55
|
48
|
44
|
24
|
19
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
2
|
0
|
0
|
235
|
225
|
125
|
81
|
60
|
11
|
10
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
150
N/A
|
217
+45%
|
221
+1%
|
346
+57%
|
316
-9%
|
186
-41%
|
136
-27%
|
115
-15%
|
45
-61%
|
36
-19%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
|
| Accrued Liabilities |
1
|
0
|
1
|
3
|
3
|
4
|
5
|
3
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
2
|
4
|
13
|
4
|
1
|
0
|
1
|
2
|
|
| Total Current Liabilities |
2
|
4
|
4
|
8
|
17
|
9
|
7
|
4
|
3
|
3
|
|
| Long-Term Debt |
19
|
21
|
16
|
52
|
48
|
53
|
36
|
14
|
9
|
10
|
|
| Minority Interest |
28
|
28
|
29
|
26
|
23
|
18
|
15
|
13
|
5
|
5
|
|
| Total Liabilities |
48
N/A
|
53
+10%
|
48
-8%
|
86
+78%
|
89
+2%
|
80
-10%
|
57
-28%
|
31
-45%
|
17
-46%
|
17
+3%
|
|
| Equity | |||||||||||
| Common Stock |
81
|
2
|
3
|
4
|
5
|
7
|
12
|
40
|
46
|
0
|
|
| Retained Earnings |
76
|
146
|
139
|
164
|
136
|
8
|
8
|
35
|
102
|
65
|
|
| Additional Paid In Capital |
81
|
0
|
19
|
37
|
40
|
44
|
48
|
72
|
80
|
80
|
|
| Other Equity |
16
|
16
|
11
|
54
|
47
|
47
|
26
|
7
|
4
|
4
|
|
| Total Equity |
102
N/A
|
165
+62%
|
172
+5%
|
259
+51%
|
228
-12%
|
106
-53%
|
79
-26%
|
84
+6%
|
28
-67%
|
19
-32%
|
|
| Total Liabilities & Equity |
150
N/A
|
217
+45%
|
221
+1%
|
346
+57%
|
316
-9%
|
186
-41%
|
136
-27%
|
115
-15%
|
45
-61%
|
36
-19%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
34
|
94
|
113
|
154
|
189
|
278
|
479
|
102
|
118
|
118
|
|
Switch to:
Switch to:
See Also
Discover More
